AEEG in Pre-term Infants
AEEG
Amplitude Electroencephalography (aEEG) Monitoring in Preterm Infants: a Feasibility Study on a Neonatal Unit aEEG in Preterm Infants
1 other identifier
interventional
21
1 country
1
Brief Summary
Amplitude integrated encephalography (aEEG) is a monitor that measures brain activity by attaching leads to a baby's head, and is used routinely in term babies who have brain injury because of a difficult birth. There is little information on how useful aEEG is in premature babies, and most studies only look at small numbers of babies. However, these studies suggest that the aEEG is different in premature babies with brain injury, infections / meningitis, and in those receiving certain drugs. It is also affected by changes in blood pressure and blood acid levels. It is theoretically possible that, if the investigators can detect changes using aEEG early on, the investigators will be able adjust treatment to make a baby better.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 30, 2018
CompletedFirst Submitted
Initial submission to the registry
April 2, 2019
CompletedFirst Posted
Study publicly available on registry
July 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedAugust 7, 2023
August 1, 2023
3.9 years
April 2, 2019
August 3, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Recruitment Rate
This is a feasibility study to inform the design of a larger multi-centre study. Rate of recruitment will determine how many centre's required for a larger study. Amount of time required to reach recruitment targets will inform average recruitment rate.
Upto 24 months after recruitment
Optimal Timing For AEEG Recording
This is a feasibility study to inform the design of a larger multi-centre study. The results of full AEEG recordings will demonstrate important time points to be recorded for larger study. Time points of abnormal brain activity will be measured and recorded.
Upto 24 months after recruitment
Study Arms (1)
AEEG monitoring
EXPERIMENTALBabies whose families consent to involvement will have their head cleaned, EEG leads attached, the monitor set up, and observations. Babies will be recorded continuously for the entire duration of their time on the intensive care unit. Once the child is receiving high dependency or special care, the investigators will record aEEG for 4 hours once a week until the baby is discharged home. If a participant is moved back to intensive care, the aEEG will be started again if the aEEG monitor is not being used on another baby. Before being discharged home, the babies will have additional follow-up. They will receive magnetic resonance imaging (MRI) of the brain on a 1.5T scanner at the University of Sheffield. They will also have a standardised examination of their neurological system performed by a physiotherapist (The Hammersmith Neonatal Neurological Examination).
Interventions
Babies will be recorded continuously for the entire duration of their time on the intensive care unit. Once the child is receiving high dependency or special care, we will record aEEG for 4 hours once a week until the baby is discharged home. If a participant is moved back to intensive care, the aEEG will be started again if the aEEG monitor is not being used on another baby.
Eligibility Criteria
You may qualify if:
- Preterm infants between 26+0 and 30+0 weeks gestational age
- Requiring intensive care following birth
- Live in Sheffield catchment area
- English speaking
- No skin viability issues on the head
- Study aEEG monitor available for use
- No known genetic, congenital structural brain abnormality, congenital infection, metabolic condition or other disorder likely to impact on neurological function independent of preterm birth
You may not qualify if:
- Under 26+0 gestational age
- Known genetic, congenital structural brain abnormality, congenital infection, metabolic condition or other disorder likely to impact on neurological function independent of preterm birth
- Non-English speakers
- Non consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jessop Wing
Sheffield, South Yorkshire, S10 2SF, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2019
First Posted
July 5, 2019
Study Start
May 30, 2018
Primary Completion
April 30, 2022
Study Completion
April 30, 2022
Last Updated
August 7, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share